Loomis, Sayles & Company
CL icon

Loomis, Sayles & Company’s Colgate-Palmolive CL Stock Holding History

Loomis, Sayles & Company’s Portfolio CL Stock Details CL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.8M Sell
56,308
-14,226
-20% -$1.27M 0.01% 415
2025
Q4 		$5.57M Sell
70,534
-53,574
-43% -$4.2M 0.01% 410
2025
Q3 		$9.92M Buy
124,108
+23,734
+24% +$2.02M 0.01% 359
2025
Q2 		$9.12M Buy
100,374
+15,197
+18% +$1.39M 0.01% 389
2025
Q1 		$7.98M Buy
85,177
+47,826
+128% +$4.28M 0.01% 381
2024
Q4 		$3.4M Buy
37,351
+36,322
+3,530% +$3.47M ﹤0.01% 434
2024
Q3 		$107K Buy
1,029
+81
+9% +$8.26K ﹤0.01% 540
2024
Q2 		$92K Sell
948
-209
-18% -$19.3K ﹤0.01% 552
2024
Q1 		$104K Sell
1,157
-218
-16% -$18.5K ﹤0.01% 537
2023
Q4 		$110K Buy
1,375
+141
+11% +$10.6K ﹤0.01% 525
2023
Q3 		$88K Buy
1,234
+162
+15% +$12.1K ﹤0.01% 537
2023
Q2 		$83K Sell
1,072
-390
-27% -$30.2K ﹤0.01% 550
2023
Q1 		$110K Sell
1,462
-526
-26% -$39.1K ﹤0.01% 532
2022
Q4 		$157K Sell
1,988
-1,484
-43% -$111K ﹤0.01% 519
2022
Q3 		$244K Buy
3,472
+711
+26% +$55.8K ﹤0.01% 455
2022
Q2 		$221K Sell
2,761
-525
-16% -$41.1K ﹤0.01% 489
2022
Q1 		$249K Sell
3,286
-9,002,661
-100% -$713M ﹤0.01% 531
2021
Q4 		$769M Sell
9,005,947
-489,935
-5% -$38.3M 0.93% 30
2021
Q3 		$718M Buy
9,495,882
+4,713
+0% +$374K 0.88% 30
2021
Q2 		$772M Sell
9,491,169
-383,472
-4% -$31.4M 0.94% 28
2021
Q1 		$778M Sell
9,874,641
-261,411
-3% -$20.5M 1.01% 27
2020
Q4 		$867M Sell
10,136,052
-663,540
-6% -$54.9M 1.15% 25
2020
Q3 		$833M Sell
10,799,592
-98,807
-0.9% -$7.53M 1.21% 26
2020
Q2 		$798M Buy
10,898,399
+183,366
+2% +$13M 1.28% 26
2020
Q1 		$711M Sell
10,715,033
-571,935
-5% -$40.3M 1.46% 24
2019
Q4 		$777M Buy
11,286,968
+441,957
+4% +$30.1M 1.32% 28
2019
Q3 		$797M Buy
10,845,011
+120,487
+1% +$8.74M 1.53% 25
2019
Q2 		$769M Buy
10,724,524
+26,496
+0.2% +$1.88M 1.44% 26
2019
Q1 		$733M Buy
10,698,028
+167,378
+2% +$10.8M 1.44% 26
2018
Q4 		$627M Sell
10,530,650
-624,635
-6% -$39.1M 1.48% 25
2018
Q3 		$747M Sell
11,155,285
-199,498
-2% -$13.3M 1.46% 23
2018
Q2 		$736M Buy
11,354,783
+9,572,470
+537% +$626M 1.49% 24
2018
Q1 		$128M Buy
1,782,313
+1,210,891
+212% +$87.1M 0.27% 42
2017
Q4 		$43.1M Buy
571,422
+4,223
+0.7% +$308K 0.09% 106
2017
Q3 		$41.3M Buy
567,199
+16,931
+3% +$1.22M 0.09% 123
2017
Q2 		$40.8M Sell
550,268
-27,516
-5% -$2.04M 0.1% 108
2017
Q1 		$42.3M Buy
577,784
+558,174
+2,846% +$39.1M 0.11% 115
2016
Q4 		$1.28M Buy
19,610
+119
+0.6% +$8.16K ﹤0.01% 582
2016
Q3 		$1.45M Buy
19,491
+12,845
+193% +$950K ﹤0.01% 575
2016
Q2 		$487K Buy
6,646
+2,924
+79% +$208K ﹤0.01% 608
2016
Q1 		$263K Buy
3,722
+1,852
+99% +$123K ﹤0.01% 628
2015
Q4 		$125K Buy
+1,870
New +$124K ﹤0.01% 693
2015
Q3 		– Sell
-281
Closed -$18K – 1026
2015
Q2 		$18K Buy
+281
New +$19.1K ﹤0.01% 761

Other funds holding CL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Loomis, Sayles & Company's CL Position: Q1 2026 in Review

Loomis, Sayles & Company reduced its Colgate-Palmolive (CL) stake by 20% in Q1 2026, selling an estimated $1.27M and leaving 56,308 shares worth $4.8M. The position accounts for 0.01% of the portfolio, ranked #415.

Loomis, Sayles & Company first reported a position in CL in Q2 2015 and has held it in 43 quarters since. The position peaked at $867M in Q4 2020. 1,946 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • Loomis, Sayles & Company held 56,308 shares of Colgate-Palmolive worth $4.8M as of Q1 2026.
  • Loomis, Sayles & Company sold 14,226 Colgate-Palmolive shares in Q1 2026, an estimated $1.27M.
  • Colgate-Palmolive made up 0.01% of Loomis, Sayles & Company's portfolio in Q1 2026, its #415 holding.
  • Loomis, Sayles & Company first reported a position in Colgate-Palmolive in Q2 2015 and has held it in 43 quarters since.
  • Loomis, Sayles & Company's Colgate-Palmolive position peaked at $867M in Q4 2020.
  • 1,946 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Loomis, Sayles & Company's 13F filing for Q1 2026, filed 14 May 2026.